within Pharmacolibrary.Drugs.ATC.J;

model J04AA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.82,
    Cl             = 7.833333333333333e-05,
    adminDuration  = 600,
    adminMass      = 4000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0156,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.007666666666666667,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J04AA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sodium aminosalicylate (para-aminosalicylic acid, PAS) is an antibiotic primarily used for the treatment of tuberculosis. It acts as a bacteriostatic agent by inhibiting folic acid synthesis in Mycobacterium tuberculosis. Previously a first-line agent in tuberculosis therapy, it is now mainly used as a second-line drug, especially for multidrug-resistant tuberculosis, owing to the availability of more effective agents. It is not widely used today except in resistant cases.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adults after oral administration.</p><h4>References</h4><ol><li><p>Ryde, EM, &amp; Ahnfelt, NO (1988). The pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without food. <i>European journal of clinical pharmacology</i> 34(5) 481–488. DOI:<a href=&quot;https://doi.org/10.1007/BF01046706&quot;>10.1007/BF01046706</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3203708/&quot;>https://pubmed.ncbi.nlm.nih.gov/3203708</a></p></li><li><p>Pooresmaeil, M, &amp; Namazi, H (2021). Developments on carboxymethyl starch-based smart systems as promising drug carriers: A review. <i>Carbohydrate polymers</i> 258 117654–None. DOI:<a href=&quot;https://doi.org/10.1016/j.carbpol.2021.117654&quot;>10.1016/j.carbpol.2021.117654</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33593542/&quot;>https://pubmed.ncbi.nlm.nih.gov/33593542</a></p></li><li><p>Chen, J, et al., &amp; Xie, F (2018). Starch film-coated microparticles for oral colon-specific drug delivery. <i>Carbohydrate polymers</i> 191 242–254. DOI:<a href=&quot;https://doi.org/10.1016/j.carbpol.2018.03.025&quot;>10.1016/j.carbpol.2018.03.025</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29661315/&quot;>https://pubmed.ncbi.nlm.nih.gov/29661315</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J04AA02;
